Base4 is a company that is redefining RNA-targeted therapeutics by using novel small molecule modulation to target previously untreatable diseases. They utilize a revolutionary structure-based discovery platform to address complex diseases in various areas, including neurology, oncology, and rare diseases. The focus is on developing innovative solutions for challenging medical conditions through their unique approach to RNA mo...
Base4 is a company that is redefining RNA-targeted therapeutics by using novel small molecule modulation to target previously untreatable diseases. They utilize a revolutionary structure-based discovery platform to address complex diseases in various areas, including neurology, oncology, and rare diseases. The focus is on developing innovative solutions for challenging medical conditions through their unique approach to RNA modulation.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.